Prostate cancer is the most frequently diagnosed cancer and the second leading cause of cancer-related death among men in the United States[1]Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression. Statistically, one in eight men